Abscopal Effect from the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
NeoplasmsSecondary Malignant Neoplasm
Interventions
RADIATION

SBRT + LDRT

Stereotactic body radiotherapy (SBRT) and low-dose radiotherapy (LDRT) are administered concurrently. SBRT is administered three times, at intervals of 1-2 days, and patients are treated with LDRT along with SBRT. LDRT is planned to irradiate EQD2 6 Gy considering the scattered dose caused by SBRT.

Trial Locations (2)

Unknown

RECRUITING

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

NOT_YET_RECRUITING

Soonchunhyang University Seoul Hospital, Seoul

All Listed Sponsors
collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Catholic University of Korea, St. Vincent Hospital

UNKNOWN

collaborator

Seoul National University Hospital

OTHER

collaborator

Chungnam National University Hospital

OTHER

lead

Soonchunhyang University Hospital

OTHER